中国儿童保健杂志 ›› 2021, Vol. 29 ›› Issue (11): 1223-1227.DOI: 10.11852/zgetbjzz2020-1919

• 综述 • 上一篇    下一篇

X-连锁低血磷性佝偻病的治疗现状及展望

李文鑫, 任立红   

  1. 哈尔滨医科大学附属第二医院儿科,黑龙江 哈尔滨 150081
  • 收稿日期:2020-11-02 修回日期:2021-03-14 发布日期:2021-11-05 出版日期:2021-11-10
  • 通讯作者: 任立红,E-mail:renlihong1@126.com
  • 作者简介:李文鑫(1994-),女,山东人,在读硕士研究生,主要研究方向为儿童保健。

Current situation and prospect of X-linked hypophosphatemia rickets

LI Wen-xin, REN Li-hong   

  1. Department of Pediatrics, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081,China
  • Received:2020-11-02 Revised:2021-03-14 Online:2021-11-10 Published:2021-11-05
  • Contact: REN Li-hong, E-mail:renlihong1@126.com

摘要: X-连锁低血磷性佝偻病(XLH)属于遗传性代谢性骨病,发病机制复杂,在临床上较为罕见,其主要临床表现为骨骼畸形及身材矮小,致残率高,因而针对XLH进行及早诊断及治疗对患者康复具有极为重要的意义。传统治疗以补充磷酸盐和维生素D类似物为主,随着学者对XLH病理机制研究逐渐深入,分子靶向治疗等新型治疗方式横空出世,通过多学科联合诊断及治疗的方法为患者带去了福音。本文就XLH的临床特征、发病遗传机制、治疗现状及治疗的未来发展趋势进行综述。

关键词: X-连锁低血磷性佝偻病, 临床特征, 发病遗传机制, 治疗方法

Abstract: X-linked hypophosphatemia rickets(XLH) is a hereditary metabolic bone disease with a complex pathogenesis and is relatively rare clinically. Its main clinical manifestations are skeletal malformation and short stature with a high disability rate. Therefore, early diagnosis and treatment of XLH is of great significance to the rehabilitation of patients. Traditional treatment mainly focuses on supplementing phosphate and vitamin D analogue. With the gradual deepening of scholars′ research on the pathological mechanism of XLH, new therapeutic methods such as molecular targeted therapy have emerged, bringing good news to patients through multidisciplinary joint diagnosis and treatment. In this paper, the clinical characteristics, pathogenesis, treatment status and future development trend of XLH will be reviewed.

Key words: X-linked hypophosphatemia rickets, clinical features, genetic mechanism, treatment

中图分类号: